ArticleFrontiers in immunology2025

Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression.

Xiaomin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.